These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through affiliate links at no additional cost to the purchaser.
The COVID-19 pandemic has mainstreamed wastewater-based epidemiology, which analyzes sewage to detect disease outbreaks. Biobot Analytics can identify current community levels of disease and opioid use from just 150 ml of an aggregate sewage sample from a 24-hour period. Because samples include everyone in a sewage system, “there’s an incredible amount of intelligence in wastewater,” says Newsha Ghaeli, Biobot’s president and co-founder. The company is the first to commercialize data from sewage. The CDC in September expanded Biobot’s contract to include monkeypox monitoring.
More Must-Reads From TIME
- Why We're Spending So Much Money Now
- The Fight to Free Evan Gershkovich
- Meet the 2024 Women of the Year
- John Kerry's Next Move
- The Quiet Work Trees Do for the Planet
- Breaker Sunny Choi Is Heading to Paris
- Column: The Internet Made Romantic Betrayal Even More Devastating
- Want Weekly Recs on What to Watch, Read, and More? Sign Up for Worth Your Time